European Stock: AstraZeneca

Company: AstraZeneca PLC

Bloomberg ticker: AZN LN

Market cap: US$200,088m

Background: AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology.
 

World Class Benchmarking of AstraZeneca

(Click on image to enlarge)

  • Profitable Growth rank of 4 was down compared to the prior period’s 3rd rank
  • This is above average performance compared to 380 large Health Care companies worldwide
  • Profitability rank of 4 was better than its Growth rank of 7
  • Profitability rank of 4 was the same compared to the prior period’s 4th rank
  • This is above average performance compared to peers
  • Growth rank of 7 was down compared to the prior period’s 1st rank
  • This is below average performance compared to peers

More By This Author:

Asian Stock: Sinopharm Group
European Stock: Prada SpA
European Stock: Burberry Group

Disclaimer: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Or Sign in with